Scottish Investment Bank has supported a funding round for Causeway Therapeutics, a spinout from University of Glasgow that is working on treatments for tendon injuries and disorders.

Cambridge Enterprise has licensed key technology to Qkine, a spinout that is working on proteins to control stem cell growth.

Paul Ashley and Brendan Ludden will be responsible for life sciences and physical sciences, respectively.

Touchstone Innovations has doubled down in its efforts to prevent a hostile takeover by rival IP Group, saying the updated offer continues to undervalue the firm.

StartX has contributed to a $20m series A round for UnifyID, the operator of an authentication platform that has now secured $23.4m.

AngelMD has put an undisclosed amount into Otomagnetics, a developer of a magnetic injection delivery system based on research at University of Maryland, College Park.

The bankrupt saltwater electrolyte battery developer had raised $190m in financing since it was spun out from Carnegie Mellon eight years ago, but was bought for less than $9.2m.

The Zell Lurie Founders Fund, the student-led investment vehicle of University of Michigan, has committed capital to brain-computer interface technology developer Neurable.